Updates on Use of Genomic Testing in Patients with High-Risk, Clinically Localized Prostate Cancer - Episode 9

Exciting Emerging Data in Prostate Cancer

August 11, 2022

Stephen J. Freedland, MD

Stephen J. Freedland, MD, highlights emerging data to look out for that might address unmet needs in prostate cancer testing and treatment.

EP. 1: Staging, Grading, and Risk Stratification of Prostate Cancer

EP. 2: Treatment Options for High-Risk, Clinically Localized Prostate Cancer

EP. 3: Clinical Challenges Surrounding Treatment Decision-Making in Clinically Localized Prostate Cancer

EP. 4: The Potential for Overtreatment or Undertreatment of Prostate Cancer

EP. 5: Addressing Clinical Challenges of Prostate Cancer Management with the Use of Genomic Testing

EP. 6: Available Genomic Tests for Clinically Localized Prostate Cancer

EP. 7: Clinical Study Data in Prostate Cancer Genomic Testing

EP. 8: Clinical Implications of Using Genomic Testing Results in Prostate Cancer Risk-Stratification and Treatment Selection

EP. 9: Exciting Emerging Data in Prostate Cancer